Malaria Scholarly Journal
Malaria could even be a mosquito-borne disease that affects humans and other animals.
Malaria source symptoms that commonly include fever, tiredness, vomiting, and headaches. Manifestation usually begin ten to fifteen days after being bitten by an infected mosquito. If not properly treated, people may have reappearance of the disease months later. In people that have recently survived an infection, reinfection usually causes milder symptoms .Malaria is caused by single-celled microorganisms of the Plasmodium group. The contamination is most ordinarily spread by an infected female Anopheles mosquito. The sting introduces the parasites from the mosquito's saliva into an individual's blood. These blood meals are the link between the human and mosquito hosts within the parasite life cycle. The successful development of the plasmodium within the mosquito depends largely on atmosphere. Higher temperatures and better humidity accelerate the parasite growth inmosquitoes. It also depends on whether the Anopheles is in a position to survive long enough to permit the parasite to finish its cycle within the mosquito host.
Malaria is transmitted to us through mosquito bites. There are a complete of three ,500
species of mosquitoes. Out of those , 430 are the Anopheles species. the feminine Anopheles mosquitoes are liable for transmitting
malaria via human hosts. Only 30 to 40 of the 430 Anopheles
species are capable of transmitting malaria.
High Impact List of Articles
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
The European Union Pediatric legislation: impact on pharmaceutical research in pediatric populations
Philippe Auby
Clinical Trail Perspective: Clinical Investigation
-
The European Union Pediatric legislation: impact on pharmaceutical research in pediatric populations
Philippe Auby
Clinical Trail Perspective: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical